Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 2

A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents

NCT ID: NCT04870762Sponsor: M.D. Anderson Cancer CenterLast updated: 2026-04-15

Summary

This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy. A customized, 3D-printed oral stent may help to reduce mouth blisters and/or sores that may develop in patients while receiving head and neck radiation therapy.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the acute mucositis rates in non-target mucosa of patients who receive head and neck radiation with or without a customized 3D printed oral stent. SECONDARY OBJECTIVES: I. To record patient reported outcomes during radiotherapy. II. To evaluate patient narcotic use during radiotherapy. III. To evaluate the imaging and dosimetric differences in head and neck radiotherapy with and without a customized 3D printed oral stent. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients wear 3D printed oral stent during standard of care radiotherapy. ARM II: Patients receive standard of care during treatment.

Arms & interventions

  • OtherBest Practice

    Receive standard of care

  • OtherMedical Device Usage and Evaluation

    Wear 3D printed oral stent

Outcome measures

Primary

  • Mucositis toxicity rates

    Rate of non-target mucose will be estimated along with the corresponding 95% confidence interval. Cochran-Mantel-Haenszel (CHM) test will be applied to compare mucositis rates between the two treatment arms. Logistic regression will be used to compare occurrence of mucositis between two arms, adjusting for the effects of stratification factors as well as other covariates. T test or Wilcoxon rank sum test will be used to compare three Olerud-Molander Ankle Score between two arms: a mean mucositis score, an extent of mucositis score, and a worst site score.

    Time frame: Through study completion, an average of 1 year

Secondary

  • Patient reported outcomes

    Time frame: Through study completion, an average of 1 year

  • Patients narcotics diaries

    Time frame: Through study completion, an average of 1 year

  • Imaging difference

    Time frame: Through study completion, an average of 1 year

  • Dosimetric difference

    Time frame: Through study completion, an average of 1 year

  • Composite pain scores

    Time frame: Through study completion, an average of 1 year

  • Number of narcotic pills used

    Time frame: Through study completion, an average of 1 year

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Participant is dispositioned to receive 5-7 weeks of definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy * Age 18 or older * ECOG PS 0-2 * The participant will receive either (a) radiation alone or (b) radiation with concurrent chemotherapy of any kind(s) * Signed study-specific consent form Exclusion Criteria: * Prior head and neck radiotherapy * Participants is unable to fit a tongue-lateralizing or tongue-depressing stent * Severe trismus with an incisal opening of \<10 mm * Inability to comply with the study procedures * Participants younger than 18 years of age * Participants must not be pregnant * Cognitively impaired subjects

Study locations (7)

Banner Health/Banner Research

Phoenix, Arizona, 85234

Recruiting
Gary V. Walker, MD · Contact
Gary V. Walker, MD · Principal Investigator

Baptist MD Anderson Cancer Center

Jacksonville, Florida, 32207

Recruiting
Mark E. Augspurger, MD · Contact
Mark E. Augspurger, MD · Principal Investigator

Community MD Anderson Cancer Center East

Indianapolis, Indiana, 46219

Recruiting
Aleander Augustyn, MD · Contact
Alexander Augustyn, MD · Principal Investigator

Community MD Anderson Cancer Center South

Indianapolis, Indiana, 46227

Recruiting
Alexander Augustyn, MD · Contact
Alexander Augustyn, MD · Principal Investigator

Community MD Anderson Cancer Center North

Indianapolis, Indiana, 46250

Recruiting
Alexander Augustyn, MD · Contact
Alexander Augustyn, MD · Principal Investigator

Cooper Hospital University Medical Center

Camden, New Jersey, 08103

Recruiting
Megan Mezera, MD · Principal Investigator

M D Anderson Cancer Center

Houston, Texas, 77030

Recruiting
Ann Lee, MD · Contact
Ann Lee, MD · Principal Investigator